Excerpted from Wisconsin State Journal
by Judy Newman
Lucigen, a Middleton biotechnology company, has received two Small Business Innovation Research grants totaling $350,000 from the National Institutes of Health.
The funds will help Lucigen develop better tools to identify which genes are being turned on in a cell at a particular moment, and that is expected to influence future drug development and personalized medicine.
They also will be used to develop a way to quickly screen for new enzymes that can multiply long strands of DNA. Lucigen will be working with Auburn University in Auburn, Ala., on that project.
